We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 420.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCRYO RNS Number : 8942M Cryo-Save Group NV 02 June 2010 2 June 2010 Cryo-Save Group N.V. Cancellation of trading of Ordinary Shares on AIM Cryo-Save Group N.V. (AIM/Euronext: CRYO, 'Cryo-Save' or 'the Group'), announces that further to the statement made by the Group on 22 March 2010 regarding the intention to de-list its ordinary shares from trading on AIM, the Group today announces that its admission to trading on AIM will be cancelled with effect from 30 June 2010 (the "Cancellation") and that in accordance with Rule 41 of the AIM Rules, the Group has notified the London Stock Exchange of the Cancellation. Cryo-Save commenced dealing of its shares on Euronext Amsterdam (the "Euronext Listing") on 22 October 2009 and by virtue of the Group having a comparable dealing facility on Euronext Amsterdam, which is an EU Regulated market, shareholder approval for the Cancellation is not required. Background to and reasons for the Cancellation Following careful consideration, the Board has concluded that in light of the Group's listing on Euronext, it is no longer in the best interests of the Group or shareholders to maintain its admission to trading on AIM. Following its listing on Euronext in October 2009, Cryo-Save has had to adhere to two separate regulatory regimes which have both cost and resource implications for the Group. The Directors feel that the cost and resource requirement of being an AIM quoted company alongside the Euronext listing does not provide the Group with significant additional benefit. The Directors believe that there will be limited impact on shareholders as a result of the Cancellation. Holders of the Depositary Interests ("DIs") that are currently traded on AIM will be able to continue to hold their DIs in CREST or convert these DIs into ordinary shares on Euronext Amsterdam. AIM shareholders As Cryo-Save is a non-UK incorporated company, UK shareholders currently hold their shares in the form of DIs which are settled through CREST. The Group intends to continue to allow its UK shareholders to hold their DIs in CREST. Therefore for those shareholders wishing to continue to maintain their holding/interest in Cryo-Save following the Cancellation, no action need be taken. Daniel Stewart and Company plc ("Daniel Stewart"), the Group's AIM nominated advisor and broker will remain the Group's UK broker following the Cancellation and in the event that UK DI holders wish to trade their Cryo-Save holdings either prior to or post the Cancellation, shareholders can continue to contact Daniel Stewart. A person currently holding shares in the form of DIs through CREST who wants to trade their shares on Euronext Amsterdam (and does not intend to continue to hold their DIs through CREST as set out above) must instruct Capita IRG Trustees Limited to cancel its DIs and transfer the underlying shares in book-entry form to the Qualifying ENL Account (see explanation below) which the relevant person needs to have or open as set out below. The cancellation of DIs in exchange for the underlying shares in book-entry form shall be effected by means of the submission of a duly completed CREST withdrawal form that can be obtained free of charge by contacting Capita IRG Trustees Limited on: +44 208 639 3135. Trading of Cryo-Save shares on Euronext Amsterdam Other than where DIs continue to be held in CREST by UK shareholders, shares traded on Euronext Amsterdam are settled in book-entry form through the book-entry facilities of Euroclear Nederland. The settlement and paying agent in relation to the Group's shares that are traded on Euronext Amsterdam is Kempen & Co N.V. Qualifying ENL Account A person who wants to trade their shares on Euronext Amsterdam must have or open an account, directly or by way of an intermediary, with an affiliated institution of Euroclear Nederland (such account, a "Qualifying ENL Account"). Persons holding shares in book-entry form A person holding shares in book-entry form within the book-entry facilities of Euroclear Nederland who wants to trade their shares on Euronext Amsterdam must instruct the affiliated institution that administers their Qualifying ENL Account or the intermediary (as applicable) accordingly. A person holding shares in registered form and who is registered on the Group's shareholder register who wants to trade their shares on Euronext Amsterdam must arrange for their shares to be included in the book-entry facilities of Euroclear Nederland. This inclusion shall be effected by means of the execution of a deed between the relevant person, Kempen & Co N.V. in its capacity as the settlement agent and ourselves. This deed can be obtained free of charge by sending a request for the deed in writing, by post, fax or e-mail to Cryo-Saveat: Cryo-Save Group N.V. IJsselkade 8 7201 HB Zutphen The Netherlands fax: + 31 575 50 91 16 e-mail: ir@cryo-save.com Alternatively, such deeds can be obtained free of charge by sending a request for the deed in writing, by post, fax or e-mail to Kempen & Co N.V.: Kempen & Co N.V. Beethovenstraat 300 1077 WZ Amsterdam The Netherlands fax: + 31 20 348 9548 e-mail: kas@kempen.nl Following the execution of the deed, the shares thus included in the book-entry facilities of Euroclear Nederland shall be credited to the Qualifying ENL Account which the relevant person needs to have or open as set out above. Enquiries: +-------------------------------------+----------------------+ | Cryo-Save Group | + 31 (0)575 548998 | +-------------------------------------+----------------------+ | Arnoud van Tulder, Chief Executive | | | Officer | | | | | +-------------------------------------+----------------------+ | Daniel Stewart & Company plc | + 44 (0)20 7776 6550 | +-------------------------------------+----------------------+ | Simon Leathers/Emma Earl | | +-------------------------------------+----------------------+ | | | +-------------------------------------+----------------------+ | College Hill (UK) | + 44 (0)20 7457 2020 | +-------------------------------------+----------------------+ | Adrian Duffield/Rozi Morris | | +-------------------------------------+----------------------+ | | | +-------------------------------------+----------------------+ | Kempen & Co N.V | | +-------------------------------------+----------------------+ | Ivo Piest | +31 (0)20 | | | 348 8511 | +-------------------------------------+----------------------+ | | | +-------------------------------------+----------------------+ | SPJ Financiële Communicatie Amstelveen (NL) | | +31 (0)20 647 8181 | +------------------------------------------------------------+ | Kees Jongsma/Léon Melens | | +-------------------------------------+----------------------+ About Cryo-Savewww.cryo-savegroup.com With more than 130,000 samples saved, Cryo-Save is the leading stem cell bank in Europe and one of the fastest growing in the world. Driven by its international business strategy, Cryo-Save is now represented in 38 countries on three continents and has state-of-the-art processing facilities in Belgium, Germany, Dubai, India and France (under construction). This information is provided by RNS The company news service from the London Stock Exchange END MSCQFLFBBQFBBBE
1 Year Cryo-Save Chart |
1 Month Cryo-Save Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions